During the past decade, Kaiser Permanente- Marshall Medical Offices conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente- Marshall Medical Offices" #1 sponsor was "National Cancer Institute (NCI)" with 9 trials, followed by "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "NRG Oncology" with 4 trials sponsored, "SWOG Cancer Research Network" with 3 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente- Marshall Medical Offices" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator and "Janssen, LP" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente- Marshall Medical Offices" are "Lung Non-Squamous Non-Small Cell Carcinoma" (2 trials), "Malignant Solid Neoplasm" (2 trials), "Metastatic Malignant Solid Neoplasm" (2 trials), "Ovarian Carcinoma" (2 trials) and "Primary Peritoneal High Grade Serous Adenocarcinoma" (2 trials). Many other conditions were trialed in "Kaiser Permanente- Marshall Medical Offices" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente- Marshall Medical Offices" are "Other" (15 trials), "Drug" (14 trials), "Procedure" (11 trials), "Biological" (9 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (9 trials), "Questionnaire Administration" (8 trials), "Biospecimen Collection" (6 trials), "Computed Tomography" (5 trials) and "Nivolumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente- Marshall Medical Offices" are 19 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Kaiser Permanente- Marshall Medical Offices". undefined are not yet recruiting, 13 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Kaiser Permanente- Marshall Medical Offices, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente- Marshall Medical Offices, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Kaiser Permanente- Marshall Medical Offices has several departments that took part in Clinical trials: "Kaiser Permanente Medical Center Lab Drawing Station" - 2 trials